-
1
-
-
84925272116
-
Texture analysis as imaging biomarker of tumoral response to neadjuvant chemoradiotherapy in rectal cancer patients studied with 3-t magnetic resonance
-
De Cecco CN, Ganeshan B, Ciolina M, Rengo M, Meinel FG, Musio D, De Felice F, Raffetto N, Tombolini V, and Laghi A (2015). Texture analysis as imaging biomarker of tumoral response to neadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance. Invest Radiol 50(4), 239–245.
-
(2015)
Invest Radiol
, vol.50
, Issue.4
, pp. 239-245
-
-
De Cecco, C.N.1
Ganeshan, B.2
Ciolina, M.3
Rengo, M.4
Meinel, F.G.5
Musio, D.6
De Felice, F.7
Raffetto, N.8
Tombolini, V.9
Laghi, A.10
-
2
-
-
84963547999
-
Clinical practice guidelines in oncology: Kidney
-
NCCN (2015). Clinical practice guidelines in oncology: kidney. Cancer 3.
-
(2015)
Cancer
, pp. 3
-
-
-
3
-
-
23044460494
-
Imaging proliferation in brain tumors with 18f-flt pet: Comparison with 18f-fdg
-
Chen W, Cloughesy T, Kamdar N, Satyamurthy N, Bergsneider M, Liau L, Mischel P, Czernin J, Phelps ME, and Silverman DH (2005). Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. J Nucl Med 46, 945–952.
-
(2005)
J Nucl Med
, vol.46
, pp. 945-952
-
-
Chen, W.1
Cloughesy, T.2
Kamdar, N.3
Satyamurthy, N.4
Bergsneider, M.5
Liau, L.6
Mischel, P.7
Czernin, J.8
Phelps, M.E.9
Silverman, D.H.10
-
4
-
-
84880445511
-
Increased intratumoral fluorothymidine uptake levels following multikinase inhibitor sorafenib treatment in a human renal cell carcinoma xenograft model
-
Murakami M, Zhao S, Zhao Y, Yu W, Fatema CN, Nishijima KI, Yamasaki M, Takiquchi M, Tamaki N, and Kuge Y (2013). Increased intratumoral fluorothymidine uptake levels following multikinase inhibitor sorafenib treatment in a human renal cell carcinoma xenograft model. Oncol Lett 6,667–672.
-
(2013)
Oncol Lett
, vol.6
, pp. 667-672
-
-
Murakami, M.1
Zhao, S.2
Zhao, Y.3
Yu, W.4
Fatema, C.N.5
Nishijima, K.I.6
Yamasaki, M.7
Takiquchi, M.8
Tamaki, N.9
Kuge, Y.10
-
5
-
-
84900325871
-
Early monitoring antiangiogenesis treatment response of sunitinib in u87mg tumor xenografft by 18f-flt micropet/ct imaging
-
Bao X, Wang M, Zhang Y, and Zhang Y (2014). Early monitoring antiangiogenesis treatment response of sunitinib in U87MG tumor xenografft by 18F-FLT MicroPET/CT Imaging. Biomed Res Int 2014,1–9 218578.
-
(2014)
Biomed Res Int 2014
, pp. 1-9
-
-
Bao, X.1
Wang, M.2
Zhang, Y.3
Zhang, Y.4
-
6
-
-
61349123591
-
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: Concensus and recommendations
-
Padhani AR, Liu G, Mu-Koh D, Chenevert TL, Thoeny HC, Takahara T, Dzik-Jurasz A, Ross BD, Van Cauteren M, and Collins D, et al (2009). Diffusion-weighted magnetic resonance imaging as a cancer biomarker: concensus and recommendations. Neoplasia 11, 102–125.
-
(2009)
Neoplasia
, vol.11
, pp. 102-125
-
-
Padhani, A.R.1
Liu, G.2
Mu-Koh, D.3
Chenevert, T.L.4
Thoeny, H.C.5
Takahara, T.6
Dzik-Jurasz, A.7
Ross, B.D.8
Van Cauteren, M.9
Collins, D.10
-
7
-
-
75349097963
-
Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: Preliminary analysis of diffusion-weighted mr imaging for early detection of tumor histopathologic downstaging
-
Sun YS, Zhang XP, Tang L, Ji JF, Gu J, Cai Y, and Zhang XY (2010). Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 254(1), 170–178.
-
(2010)
Radiology
, vol.254
, Issue.1
, pp. 170-178
-
-
Sun, Y.S.1
Zhang, X.P.2
Tang, L.3
Ji, J.F.4
Gu, J.5
Cai, Y.6
Zhang, X.Y.7
-
8
-
-
84920433556
-
Clinical oncologic applications of pet/mri: A new horizon
-
Partovi S, Dohan A, Rubbert C, Vercher-Conejero JL, Gaeta C, Yuh R, Zipp L, Herrmann KA, Robbin MR, and Lee Z, et al (2014). Clinical oncologic applications of PET/MRI: a new horizon. Am J Nucl Med Mol Imaging 4, 202–212.
-
(2014)
Am J Nucl Med Mol Imaging 4
, pp. 202-212
-
-
Partovi, S.1
Dohan, A.2
Rubbert, C.3
Vercher-Conejero, J.L.4
Gaeta, C.5
Yuh, R.6
Zipp, L.7
Herrmann, K.A.8
Robbin, M.R.9
Lee, Z.10
-
9
-
-
57849117384
-
New response evaluation criteria in solid tumours: Revised recist guideline (version 1.1)
-
Eisenhuuer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, and Mooney M, et al (2009). New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45,228–247.
-
(2009)
Eur J Cancer 45
, pp. 228-247
-
-
Eisenhuuer, E.A.1
Therasse, P.2
Bogaerts, J.3
Schwartz, L.H.4
Sargent, D.5
Ford, R.6
Dancey, J.7
Arbuck, S.8
Gwyther, S.9
Mooney, M.10
-
10
-
-
84871914316
-
Mri assessment of early tumor response in metastatic renal cell carcinoma patients treated with sorafenib
-
Kang HC, Tan K, Keefe SM, Heitjan DF, Siegelman ES, Flaherty KT, O'Dwyer PJ, and Rosen MA (2013). MRI assessment of early tumor response in metastatic renal cell carcinoma patients treated with sorafenib. AJR Am J Roentgenol 200, 120–126.
-
(2013)
AJR am J Roentgenol
, vol.200
, pp. 120-126
-
-
Kang, H.C.1
Tan, K.2
Keefe, S.M.3
Heitjan, D.F.4
Siegelman, E.S.5
Flaherty, K.T.6
O'dwyer, P.J.7
Rosen, M.A.8
-
11
-
-
66149139452
-
From recist to percist: Evolving considerations for pet response criteria in solid tumors
-
Wahl RL, Jacene H, Kasamon Y, and Lodge MA (2009). From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 50(Suppl 1), 122S–150S.
-
(2009)
J Nucl Med
, vol.50
, pp. 122S-150S
-
-
Wahl, R.L.1
Jacene, H.2
Kasamon, Y.3
Lodge, M.A.4
-
12
-
-
84863336576
-
Imaging-based tumor treatment response evaluation: Review of conventional, new, and emerging concepts
-
Hee K, Lee HY, Lee KS, and Kim JH (2012). Imaging-based tumor treatment response evaluation: review of conventional, new, and emerging concepts. Korean J Radiol 13(4), 371–390.
-
(2012)
Korean J Radiol
, vol.13
, Issue.4
, pp. 371-390
-
-
Hee, K.1
Lee, H.Y.2
Lee, K.S.3
Kim, J.H.4
-
13
-
-
0043237770
-
Image registration methods: A survey
-
Zitova B and Flusser J (2003). Image registration methods: a survey. Imag Vis Comput 21, 977–1000.
-
(2003)
Imag Vis Comput
, vol.21
, pp. 977-1000
-
-
Zitova, B.1
Flusser, J.2
-
14
-
-
84862283408
-
Interplay between bias field correction, intensity standardization, and noise filtering for t2-weighted mri
-
Palumb D, Yee B, and Madabhushi A (2011). Interplay between bias field correction, intensity standardization, and noise filtering for T2-weighted MRI. Conf Proc IEEE Eng Med Biol Soc 2011, 5080–5083.
-
(2011)
Conf Proc IEEE Eng Med Biol Soc
, vol.2011
, pp. 5080-5083
-
-
Palumb, D.1
Yee, B.2
Madabhushi, A.3
-
15
-
-
84857037061
-
Radiomics: Extracting more information from medical images using advanced feature analysis
-
Lambin P, Rios-Velazquez E, Leinjenaar R, Carvalho S, van Stiphout RG, Granton P, Zegers CM, Gillies R, Boellard R, and Dekker A, et al (2012). Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48(4), 441–446.
-
(2012)
Eur J Cancer
, vol.48
, Issue.4
, pp. 441-446
-
-
Lambin, P.1
Rios-Velazquez, E.2
Leinjenaar, R.3
Carvalho, S.4
Van Stiphout, R.G.5
Granton, P.6
Zegers, C.M.7
Gillies, R.8
Boellard, R.9
Dekker, A.10
-
16
-
-
84906066693
-
Identifying quantitative in vivo multi-parameteric mri features for treatment related changes after laster interstitial thermal therapy of prostate cancer
-
Viswanath S, Toth R, Rusu M, Sperling D, Lepor H, Futterer J, and Madabhushi A (2014). Identifying quantitative in vivo multi-parameteric MRI features for treatment related changes after laster interstitial thermal therapy of prostate cancer. Neurocomputing 144, 13–23.
-
(2014)
Neurocomputing
, vol.144
, pp. 13-23
-
-
Viswanath, S.1
Toth, R.2
Rusu, M.3
Sperling, D.4
Lepor, H.5
Futterer, J.6
Madabhushi, A.7
-
17
-
-
84862736916
-
Central gland and peripheral zone prostate tumors have significantly different quantitative signatures on 3 tesla endorectal in vivo t2-weighted mr imagery
-
Viswanath SE, Bloch NB, Chappelow JC, Toth R, Rofsky NM, Genega EM, Lenkinski RE, and Madabhushi A (2012). Central gland and peripheral zone prostate tumors have significantly different quantitative signatures on 3 tesla endorectal in vivo T2-weighted MR imagery. J Magn Reson Imaging 36, 213–224.
-
(2012)
J Magn Reson Imaging
, vol.36
, pp. 213-224
-
-
Viswanath, S.E.1
Bloch, N.B.2
Chappelow, J.C.3
Toth, R.4
Rofsky, N.M.5
Genega, E.M.6
Lenkinski, R.E.7
Madabhushi, A.8
-
18
-
-
84902105409
-
Computer extracted texture features on t2w mri to predict biochemical recurrence following radiation therapy for prostate cancer
-
Ginsburh S, Rusu M, Kurhanewicz J, and Madabhushi A (2014). Computer extracted texture features on T2w MRI to predict biochemical recurrence following radiation therapy for prostate cancer. Proc SPIE Int Med Imag 9035(903509), 1–13.
-
(2014)
Proc SPIE Int Med Imag
, vol.9035
, pp. 1-13
-
-
Ginsburh, S.1
Rusu, M.2
Kurhanewicz, J.3
Madabhushi, A.4
-
19
-
-
85006770978
-
Quantitative identification of magnetic resonance imaging features of prostate cancer response following laser ablation and radical prostatectomy
-
Litjens G, Huisman H, Elliot R, Shih NN, Feldman MD, Viswanath S, Futterer JJ, Boomers JG, and Madabhushi A (2014). Quantitative identification of magnetic resonance imaging features of prostate cancer response following laser ablation and radical prostatectomy. J Med Imaging 1(3), 035001.
-
(2014)
J Med Imaging 1(3)
-
-
Litjens, G.1
Huisman, H.2
Elliot, R.3
Shih, N.N.4
Feldman, M.D.5
Viswanath, S.6
Futterer, J.J.7
Boomers, J.G.8
Madabhushi, A.9
-
20
-
-
33846181370
-
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
-
Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, and Kim ST, et al (2007). Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356, 115–124.
-
(2007)
N Engl J Med
, vol.356
, pp. 115-124
-
-
Motzer, R.J.1
Hutson, T.E.2
Tomczak, P.3
Michaelson, M.D.4
Bukowski, R.M.5
Rixe, O.6
Oudard, S.7
Negrier, S.8
Szczylik, C.9
Kim, S.T.10
-
21
-
-
33644833910
-
Activity of su11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma
-
Motzer RJ, Michaelson MD, Redman BG, Hudes GR, Wilding G, Figlin RA, Ginsberg MS, Kim ST, Baum CM, and DePrimo SE (2006). Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol 24, 16–24.
-
(2006)
J Clin Oncol
, vol.24
, pp. 16-24
-
-
Motzer, R.J.1
Michaelson, M.D.2
Redman, B.G.3
Hudes, G.R.4
Wilding, G.5
Figlin, R.A.6
Ginsberg, M.S.7
Kim, S.T.8
Baum, C.M.9
Deprimo, S.E.10
-
22
-
-
33744984843
-
Phase ii placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma
-
Ratain MJ, Eisen T, Stadler WM, Flaherty KT, Kaye SB, Rosner GL, Gore M, Desai AA, Patnaik A, and Xiong HQ, et al (2006). Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. J Clin Oncol 24, 2505–2512.
-
(2006)
J Clin Oncol
, vol.24
, pp. 2505-2512
-
-
Ratain, M.J.1
Eisen, T.2
Stadler, W.M.3
Flaherty, K.T.4
Kaye, S.B.5
Rosner, G.L.6
Gore, M.7
Desai, A.A.8
Patnaik, A.9
Xiong, H.Q.10
-
23
-
-
33846148701
-
Sorafenib in advanced clear-cell renal-cell carcinoma
-
Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, and Desai AA, et al (2007). Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356, 125–134.
-
(2007)
N Engl J Med
, vol.356
, pp. 125-134
-
-
Escudier, B.1
Eisen, T.2
Stadler, W.M.3
Szczylik, C.4
Oudard, S.5
Siebels, M.6
Negrier, S.7
Chevreau, C.8
Solska, E.9
Desai, A.A.10
-
24
-
-
33644847440
-
Safety, pharmacokinetic, and antitumor activity of su11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer
-
Faivre S, Delbaldo C, Vera K, Robert C, Lozahic S, Lassau N, Bello C, Deprimo S, Brega N, and Massimini G, et al (2006). Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer. J Clin Oncol 24, 25–35.
-
(2006)
J Clin Oncol
, vol.24
, pp. 25-35
-
-
Faivre, S.1
Delbaldo, C.2
Vera, K.3
Robert, C.4
Lozahic, S.5
Lassau, N.6
Bello, C.7
Deprimo, S.8
Brega, N.9
Massimini, G.10
-
25
-
-
33947504730
-
Sunitinib: From rational design to clinical efficacy
-
Chow LQ and Eckhardt SG (2007). Sunitinib: from rational design to clinical efficacy. J Clin Oncol 25, 884–896.
-
(2007)
J Clin Oncol
, vol.25
, pp. 884-896
-
-
Chow, L.Q.1
Eckhardt, S.G.2
-
26
-
-
0023064533
-
Image non-uniformity in magnetic resonance imaging: Its magnitude and methods for its correction
-
Condon BR, Patterson J, Wyper D, Jenkins A, and Hadley DM (1987). Image non-uniformity in magnetic resonance imaging: its magnitude and methods for its correction. Br J Radiol 60(709), 83–87.
-
(1987)
Br J Radiol
, vol.60
, Issue.709
, pp. 83-87
-
-
Condon, B.R.1
Patterson, J.2
Wyper, D.3
Jenkins, A.4
Hadley, D.M.5
-
27
-
-
33847774807
-
A review of methods for correction of intensity inhomogeneity in mri
-
Vovk U, Pernus F, and Likar B (2007). A review of methods for correction of intensity inhomogeneity in MRI. IEEE Trans Med Imaging 26(3), 405–421.
-
(2007)
IEEE Trans Med Imaging
, vol.26
, Issue.3
, pp. 405-421
-
-
Vovk, U.1
Pernus, F.2
Likar, B.3
-
28
-
-
0033853121
-
Rapid and effective correction of rf inhomogeneity for high field magnetic resonance imaging
-
Cohen M, DuBois R, and Zeineh M (2000). Rapid and effective correction of RF inhomogeneity for high field magnetic resonance imaging. Hum Brain Mapp 10, 204–211.
-
(2000)
Hum Brain Mapp
, vol.10
, pp. 204-211
-
-
Cohen, M.1
Dubois, R.2
Zeineh, M.3
-
29
-
-
73849116467
-
Elastix: A toolbox for intensity based medical image registration
-
Klein S, Staring M, Murphy K, Viergever MA, and Pluim JPW (2010). elastix: a toolbox for intensity based medical image registration. IEEE Trans Med Imaging 29(1), 96–205.
-
(2010)
IEEE Trans Med Imaging
, vol.29
, Issue.1
, pp. 96-205
-
-
Klein, S.1
Staring, M.2
Murphy, K.3
Viergever, M.A.4
Pluim, J.P.W.5
-
30
-
-
0033624997
-
New variants of a method of mri scale standardization
-
Nyul LG, Udupa JK, and Zhang X (2000). New variants of a method of MRI scale standardization. IEEE Trans Med Imaging 19(2), 143–150.
-
(2000)
IEEE Trans Med Imaging
, vol.19
, Issue.2
, pp. 143-150
-
-
Nyul, L.G.1
Udupa, J.K.2
Zhang, X.3
-
32
-
-
80052876547
-
Textural kinetics: A novel dynamic contrast-enhanced (dce)-mri feature for breast lesion classification
-
Agner SC, Soman S, Libfeld E, McDonald M, Thomas K, Englander S, Rosen MA, Chin D, Nosher J, and Madabhushi A (2010). Textural kinetics: a novel dynamic contrast-enhanced (DCE)-MRI feature for breast lesion classification. J Digit Imaging 24, 446–463.
-
(2010)
J Digit Imaging
, vol.24
, pp. 446-463
-
-
Agner, S.C.1
Soman, S.2
Libfeld, E.3
McDonald, M.4
Thomas, K.5
Englander, S.6
Rosen, M.A.7
Chin, D.8
Nosher, J.9
Madabhushi, A.10
-
34
-
-
84894815316
-
The effect of small tumor volumes on studies of intratumoral heterogeneity of tracer uptake
-
Brooks FH and Grigsby PW (2014). The effect of small tumor volumes on studies of intratumoral heterogeneity of tracer uptake. J Nucl Med 55, 37–42.
-
(2014)
J Nucl Med
, vol.55
, pp. 37-42
-
-
Brooks, F.H.1
Grigsby, P.W.2
-
35
-
-
84899486643
-
Tumor texture analysis in 18f-fdg pet: Relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysis
-
Orlhac F, Soussan M, Maisonobe JA, Garcia CA, Vanderlinden B, and Buvat I (2014). Tumor texture analysis in 18F-FDG PET: relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysis. J Nucl Med 55, 414–422.
-
(2014)
J Nucl Med
, vol.55
, pp. 414-422
-
-
Orlhac, F.1
Soussan, M.2
Maisonobe, J.A.3
Garcia, C.A.4
Vanderlinden, B.5
Buvat, I.6
-
36
-
-
84920454196
-
18f-fdg pet uptake characterization through texture analysis: Investigating the complementary nature of heterogeneity and functional tumor volume in a multi–cancer site patient cohort
-
18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi–cancer site patient cohort. J Nucl Med 56(1), 38–44.
-
(2015)
J Nucl Med
, vol.56
, Issue.1
, pp. 38-44
-
-
Hatt, M.1
Majdoub, M.2
Vallieres, M.3
Tixier, F.4
Le Rest, C.C.5
Groheux, D.6
Hindie, E.7
Martineau, A.8
Pradier, O.9
Hustinx, R.10
-
37
-
-
65249157560
-
The divergence and bhattacharyya distance measures in signal selection
-
Kailath T (1967). The divergence and Bhattacharyya distance measures in signal selection. IEEE Trans Commun Technol 15(1), 52–60.
-
(1967)
IEEE Trans Commun Technol
, vol.15
, Issue.1
, pp. 52-60
-
-
Kailath, T.1
-
38
-
-
84920408854
-
Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [f-18]fluorothymidine-positron emission tomography-magnetic resonance
-
Valls L, Hoimes C, Sher A, Hu L, Lee Z, Muzic R, and Avril N (2014). Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance. Semin Roentgenol 49(3), 238–241.
-
(2014)
Semin Roentgenol
, vol.49
, Issue.3
, pp. 238-241
-
-
Valls, L.1
Hoimes, C.2
Sher, A.3
Hu, L.4
Lee, Z.5
Muzic, R.6
Avril, N.7
-
39
-
-
78650889076
-
Prostate cancer characterization on mr images using fractal features
-
Lopes R, Ayache A, Makni N, Puech P, Villers A, Mordon S, and Betrouni N (2010). Prostate cancer characterization on MR images using fractal features. Med Phys 38, 83–95.
-
(2010)
Med Phys
, vol.38
, pp. 83-95
-
-
Lopes, R.1
Ayache, A.2
Makni, N.3
Puech, P.4
Villers, A.5
Mordon, S.6
Betrouni, N.7
|